A novel real-time duplex PCR assay for detecting penA and ponA genotypes in Neisseria gonorrhoeae: comparison with phenotypes determined by the E-Test.
Recent advances in PCR have made it possible to use clinical samples to characterize both the pathogenic agent and its susceptibility to antimicrobial drugs (7-10). A recently validated real-time PCR assay (10) has been used for rapid detection of a ponA variation associated with a decreased susceptibility to penicillin. This method confirmed the phenotype, but the variation in the ponA gene was not the sole alteration involved. Because the resistance mechanisms are based on stepwise accumulation of point variations correlating with increased MICs (11-13), an improvement was imperative to differentiate NG strains with intermediate susceptibility to penicillin (0.06 mg/L < MIC < 1 mg/L). In this study, we used both conventional bacteriologic methods and a novel real-time PCR assay to identify all gonococci isolated in New Caledonia since July 2003 and to determine whether phenotypes obtained by E-test correlate with genotypes identified by melting curve analysis after amplification of specific gene sequences.
We collected a total of 120 NG strains in the bacteriology laboratory of the Institut Pasteur in New Caledonia. The identity of the organism was confirmed by specific characteristics after culture on chocolate agar supplemented with PolyVitex plus colistin, vancomycin, amphotericin B, and trimethoprim antibiotics (bioMerieux SA). MICs of penicillin were determined by E-test (AB Biodisk) on chocolate agar PolyVitex. To check the presence of [beta]-lactamase, all clinical isolates were subjected to cefinase test (bioMerieux SA, France); only 1 strain showed a positive result, indicating the presence of plasmid-mediated penicillin resistance. The real-time monoplex PCR (10) allowed rapid screening of clinical samples for penicillin-resistant NG strains. Two hybridization probes were used to distinguish the wild-type ponA gene from the variant gene ([Leu.sup.421] [right arrow] Pro). In our novel duplex PCR, 2 additional hybridization probes and primers were used to enable real-time PCR detection of the aspartic acid residue (Asp-345A) in the NG penA gene. Template DNA was purified from positive cultures with a QIAamp DNA Minikit (Qiagen) according to the manufacturer's instructions. Primers, as well as probes, were designed with the LightCycler Probe Design software version 2.0 (Roche Diagnostics) and were synthesized by Proligo Singapore Pte. Ltd. Primers and probes targeting the ponA gene were previously described (10). Oligonucleotides targeting penA included the following: penA-F (5'-GAC CTT GGC CTA TGA AGA G-3'), penA-R (5'-GGT TAC GGA AAC CAT CAG ATT-3'), sensor probe penA-P1 (5'-CGC GAC GAT ACC CAT GTT TAC C-fluorescein-3'), and anchor probe penA-P2 (5'-LC-Red 640-TCT TTG GAT GTG CGC GGC ATT ATG CA-phosphate-3'). Reactions were performed in 20-[micro]L capillaries (2 [micro]L of sample DNA and 18 [micro]L of master mix) as previously described (10), with final concentrations of probes of 0.2 [micro]M. As in our original assay (10), we used asymmetric primer concentrations (forward primers, 0.5 [micro]mol/L; reverse primers, 1 [micro]mol/L) as recommended by Barratt and Mackay (14) to improve real-time signal. Controls in every test assay included blanks and wild-type strains, strains with one variation, and strains with both variations, as determined by sequencing. Fluorescence was measured during the annealing step as a ratio of the emitted fluorescence in channel 640 (penA insert) or in channel 705 (ponA variation) to emitted fluorescence in channel 530. Color compensation to eliminate any fluorescent signal of LC-Red 640 in channel 705 was performed according to manufacturer's instructions. Analytical sensitivity was determined with serial 10-fold dilutions of gonococcal DNA; amplification was observed in a corresponding interval of 5 x [10.sup.9] to 5 x [10.sup.2] genome copies per reaction according to Overbergh's formula (15). To investigate the specificity of our test, we also tested 2 strains of Neisseria lactamica [Collection Institut Pasteur (CIP) 73.27, CIP 107857] and 1 Neisseria cinerea strain (CIP 73.16T) obtained from the CIP in France. To further investigate the specificity of our assay, the DNA of non-Neisseria species, including Mycoplasma hominis, Ureaplasma urealyticum, Trichomonas vaginalis, Candida albicans, and other gram-positive and gram-negative bacteria (Gardnerella vaginalis, Streptococcus agalactiae, Streptococcus faecalis, Staphylococcus aureus, and Escherichia coli) were also purified and subjected to our real-time assay. No amplification was detected for these strains, a result that confirmed the specificity of our duplex assay.
Oligonucleotide hybridization and melting analysis with fluorescein and LC-Red 640 probes generated 2 distinct melting temperature ([T.sub.m]) curves (Fig. 1A), permitting differentiation between wild-type and insert Asp345A in penA genes. Differentiation of the single-base variation in the ponA gene was also possible with fluorescein and LC-Red 705 probes (Fig. 1B). Variations in [T.sub.m] (1.0[degrees]C) may occur because amounts of DNA from culture may be much larger than those obtained from patients samples (data not shown), but such variations did not affect the [T.sub.m] shift or the shape of the curves in our study. Of 120 NG strains, 59 showed MICs for penicillin of 0.008-0.06 mg/L ([Pen.sup.s]), 43 were classified as intermediate (Pen') with MICs of 0.06-0.75 mg/L, and 18 as resistant ([Pen.sup.1]) with MICs [greater than or equal to]1 mg/L (Table 1).
It is noteworthy that 36 of 38 Pens with MIC [less than or equal to] 0.016 mg/L peaked at a mean (SD) [T.sub.m] of 60.0 (0.5)[degrees]C, specific for the wild-type penA genotype, whereas 2 peaked at 65.0 (0.5)[degrees]C, indicating the presence of the Asp-345A insert. The altered penA [T.sub.m] was observed for 3 of 9 strains with MIC = 0.032 mg/L, and the Asp-345A+ [T.sub.m] for 9 of 12 strains with MIC = 0.047 mg/L. All of these NG Pens were wild-type ponA [[T.sub.m] 61.0 (0.5)[degrees]C].
Residue Asp-345A was found in 37 of 43 Pen'. Except for 1 strain, all wild-type penA among the Pen' strains showed an MIC to penicillin of 0.064 mg/L. We considered an MIC of 0.094 mg/L as a cutoff point because all NG strains (except 1) with MIC >0.064 mg/L had penA genes with [T.sub.m]s indicating the presence of the Asp-345A insertion. Complete concordance was demonstrated except for 1 discrepancy, which suggested a possible contribution of other chromosomally mediated resistance mechanisms. Interestingly, 11 of the Pen' strains also showed a variant ponA genotype, indicating that this alteration was present in fewer than expected penicillin phenotypes. All [Pen.sup.R] strains included in this study showed the presence of both penA and ponA variant genotypes. The biological significance of these findings is related to specific mechanisms involved in chromosomally mediated antibiotic resistance to penicillin in NG. The 5 genes involved in resistance to penicillin interact in a specific manner. Briefly, in transformation and homologous recombination experiments (4), genes are transferred from a resistant strain to a susceptible strain in a specific order, the altered ponA and penC genes being the last to be reported in the sequence of events leading to resistance. Thus, no apparent increase in resistance occurred in strains with ponA variations unless penA, mtrR, penB, and penC resistance determinants were also present. These specific relationships could explain why the phenotypical absence of resistance in strains with low penicillin MICs, despite the presence of the variant ponA gene. In addition to insertion, simultaneous variations in penA can also contribute to resistance (16). The presence of strains harboring the insertion in penA but lacking these previous point variations may also explain the detection of low MICs of penicillin.
[FIGURE 1 OMITTED]
Finally, DNAs of 10 NG strains with different genotypes differentiated by their [T.sub.m] were amplified, purified, and sent to the Auckland University DNA sequencing facility (Auckland, New Zealand). Nucleotide sequencing data were in complete agreement with multiplex assay results. All experiments were performed in triplicate, and our results were fully reproducible. They were confirmed by conventional sequencing and correlated with phenotypes obtained by E-test. Our protocol was shown to be a good method for CMRNG detection and genotyping studies. Moreover, our method could be a valuable molecular tool in an effective antimicrobial strategy to control gonococci.
DOI : 10.1373/clinchem.2006.075309
(1.) Easmon CSF. The changing pattern of antibiotic resistance of Neisseria gonorrhoeae. Genitourin Med 1990;66:55-6.
(2.) Herida M, Sednaoui P, Goulet V. Gonorrhoea surveillance system in France: 1986-2000. Sex Transm Dis 2004;4:209-14.
(3.) Ito M, Yasuda M, Yokoi S, Ito S, Takahashi Y, Ishihara S, et al. Remarkable increase in Central Japan in 2001-2002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones. Antimicrob Agents Chemother 2004;48:3185-7.
(4.) Brannigan JA, Tirodimos IA, Zhang QY, Dowson CG, Spratt BG. Insertion of an extra amino acid is the main cause of the low affinity of penicillin-binding protein 2 in penicillin-resistant strains of Neisseria gonorrhoeae. Mol Microbiol 1990;4:913-9.
(5.) Dowson CG, Jephcott AE, Gough KR, Spratt BG. Penicillin-binding protein 2 genes of non-[beta]-lactamase-producing, penicillin-resistant strains of Neisseria gonorrhoeae. Mol Microbiol 1989;3:35-41.
(6.) Ropp PA, Hu M, Olesky M, Nicholas RA. Mutations in ponA, the gene encoding penicillin-binding protein 1, and a novel locus, penC, are required for high-level chromosomally mediated penicillin resistance in Neisseria gonorrhoeae. Antimicrob Agents Chemother 2002;46:769-777.
(7.) Paule SM, Trick WE, Tenover FC, Lankford M, Cunningham S, Stosor V, et al. Comparison of PCR assay to culture for surveillance detection of vancomycin-resistant enterococci. J Clin Microbiol 2003;41:4805-7.
(8.) Lapierre P, Huletsky A, Fortin V, Picard FJ, Roy PH, Ouellette M, et al. Real-time PCR assay for detection of fluoroquinolone resistance associated with gr1A mutations in Staphylococcus aureus. J Clin Microbiol 2003;41: 3246-51.
(9.) Stefanelli P, Carattoli A, Neri A, Fazio C, Mastrantonio P. Prediction of decreased susceptibility to penicillin of Neisseria meningitides strains by real-time PCR. J Clin Microbiol 2003;41:4666-70.
(10.) Vernel-Pauillac F, Falcot V, Whiley D, Merien F. Rapid detection of a chromosomally mediated penicillin resistance-associated ponA mutation in Neisseria gonorrhoeae using a real-time PCR assay. FEMS Microbiol Lett 2006;255:66-74.
(11.) Olesky M, Hobbs M, Nicholas RA. Identification and analysis of amino acid mutations in porin IB that mediate intermediate-level resistance to penicillin and tetracycline in Neisseria gonorrhoeae. Antimicrob Agents Chemother 2002;46:2811-20.
(12.) Tirodimos I, Tzelepi E, Katsougiannopoulos VC. Penicillin-binding protein 2 genes of chromosomally-mediated penicillin-resistant Neisseria gonorrhoeae from Greece: screening for codon Asp-345A. J Antimicrob Chemother 1993;32:677-84.
(13.) Veal WL, Nicholas RA, Shafer WM. Overexpression of the MtrC- MtrD- MtrE efflux pump due to an mtrR mutation is required for chromosomally mediated penicillin resistance in Neisseria gonorrhoeae. J Bacteriol 2002; 184:5619-24.
(14.) Barratt K, Mackay JF. Improving real-time PCR genotyping assays by asymmetric amplification. J Clin Microbiol 2002;10:1571-2.
(15.) Overbergh L, Giulietti A, Valckx D, Decallonne R, Bouillon R, Mathieu C. The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J Biomol Tech 2003;14:33-43.
(16.) Mavroidi A, Tzouvelekis LS, Kyriakis KP, Avgerinou H, Daniilidou M, Tzelepi E. Multidrug-resistant strains of Neisseria gonorrhoeae in Greece. Antimicrob Agents Chemother 2001;45:2651-4.
Frederique Vernel-Pauillac, and Fabrice Merien * (Laboratoire de Recherche en Bacteriologie, Institut Pasteur de Nouvelle-Caledonie, Nouvelle-Caledonie; * Address correspondence to this author at: Institut Pasteur of New Caledonia, BP 61 98845 Noumea cedex, New Caledonia. Fax 00-687-27-33-90; e-mail email@example.com.
Table 1. Characteristics of NG isolates used in this study. Mic of Number penicillin, Phenotypic of strains mg/L status penA genotype 38 [less than S (a) Asp-345A: 2/38 or equal to] 0.016 9 0.032 S Asp-345A: 3/9 12 0.047 S Asp-345A: 9/12 8 0.064 I Asp-345A: 3/8 7 0.094 I Asp-345A: 7/7 3 0.19 I Asp-345A: 3/3 8 0.125 I Asp-345A: 8/8 6 0.25 I Asp-345A: 6/6 7 0.38 I Asp-345A: 6/7 2 0.50 I Asp-345A: 2/2 2 0.75 I Asp-345A: 2/2 18 [less than R Asp-345A: 18/18 or equal to] 1 Number of strains ponA genotype 38 ponA variant: 0/38 9 ponA variant: 0/9 12 ponA variant: 0/12 8 ponA variant: 1/8 7 ponA variant: 0/7 3 ponA variant: 1/3 8 ponA variant: 1/8 6 ponA variant: 2/6 7 ponA variant: 4/7 2 ponA variant: 0/2 2 ponA variant: 2/2 18 ponA variant: 18/18 (a) S, susceptible; I, intermediate; R, resistant.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Technical Briefs|
|Author:||Vernel-Pauillac, Frederique; Merien, Fabrice|
|Date:||Dec 1, 2006|
|Previous Article:||Persistent hypercalcemia after parathyroidectomy in an adolescent and effect of treatment with cinacalcet HCL.|
|Next Article:||Quantification of urinary oxalate by liquid chromatography-tandem mass spectrometry with online weak anion exchange chromatography.|